Literature DB >> 18716556

Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma.

Eli E Bar1, Alex Lin, Tarik Tihan, Peter C Burger, Charles G Eberhart.   

Abstract

Relatively little is known about the molecular changes that promote the formation or growth of pilocytic astrocytomas. We investigated genomic alterations in 25 pilocytic astrocytomas, including 5 supratentorial and 20 posterior fossa tumors, using oligonucleotide array comparative genomic hybridization. Large changes were identified in 7 tumors and included gains of chromosomes 5, 6, and 7 and losses of chromosomes 16, 17, 19, and 22. The most common alteration was a 1.9-MB region of low-level gain at chromosome 7q34 identified in 17 of 20 posterior fossa tumors. In most tumors, the region of gain ended within the BRAF locus and encompassed only exons that encode the BRAF kinase domain. We confirmed copy number increase at the 7q34 locus using quantitative polymerase chain reaction with primers adjacent to the HIPK2, RAB19B, and BRAF genes. Western blot analysis revealed that 3 of 6 pilocytic astrocytomas with 7q34 gain contained high levels of phosphorylated extracellular signal-related kinase (ERK) and nitrogen-activated protein kinase/ERK kinase (MEK), while 1 tumor lacking 7q34 gain and 2 normal brain specimens did not. Immunohistochemical stains of a tissue microarray containing 43 pilocytic astrocytoma identified ERK phosphorylation in 35 (81%). These data indicate that focal gains at chromosome 7q34 and increased BRAF-MEK-ERK signaling are common findings in sporadic pilocytic astrocytomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716556     DOI: 10.1097/NEN.0b013e3181845622

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  100 in total

Review 1.  Molecular insights into pediatric brain tumors have the potential to transform therapy.

Authors:  Amar Gajjar; Stefan M Pfister; Michael D Taylor; Richard J Gilbertson
Journal:  Clin Cancer Res       Date:  2014-11-15       Impact factor: 12.531

2.  BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model.

Authors:  Eric H Raabe; Kah Suan Lim; Julia M Kim; Alan Meeker; Xing-Gang Mao; Guido Nikkhah; Jarek Maciaczyk; Ulf Kahlert; Deepali Jain; Eli Bar; Kenneth J Cohen; Charles G Eberhart
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

3.  Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma.

Authors:  Barbara S Paugh; Alberto Broniscer; Chunxu Qu; Claudia P Miller; Junyuan Zhang; Ruth G Tatevossian; James M Olson; J Russell Geyer; Susan N Chi; Nasjla Saba da Silva; Arzu Onar-Thomas; Justin N Baker; Amar Gajjar; David W Ellison; Suzanne J Baker
Journal:  J Clin Oncol       Date:  2011-09-19       Impact factor: 44.544

Review 4.  The evolving molecular genetics of low-grade glioma.

Authors:  Sriram Venneti; Jason T Huse
Journal:  Adv Anat Pathol       Date:  2015-03       Impact factor: 3.875

Review 5.  Update on molecular findings, management and outcome in low-grade gliomas.

Authors:  T David Bourne; David Schiff
Journal:  Nat Rev Neurol       Date:  2010-11-02       Impact factor: 42.937

6.  Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target.

Authors:  Marianne Hütt-Cabezas; Matthias A Karajannis; David Zagzag; Smit Shah; Iren Horkayne-Szakaly; Elisabeth J Rushing; J Douglas Cameron; Deepali Jain; Charles G Eberhart; Eric H Raabe; Fausto J Rodriguez
Journal:  Neuro Oncol       Date:  2013-11-06       Impact factor: 12.300

Review 7.  Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

Authors:  Trent R Hummel; Lionel M Chow; Maryam Fouladi; David Franz
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

Review 8.  The molecular biology of WHO grade I astrocytomas.

Authors:  Nicholas F Marko; Robert J Weil
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

9.  Something old and something new about molecular diagnostics in gliomas.

Authors:  Craig Horbinski
Journal:  Surg Pathol Clin       Date:  2012-12-01

10.  BRAF alterations in pediatric low grade gliomas and mixed neuronal-glial tumors.

Authors:  Efthymios Dimitriadis; George A Alexiou; Panagiota Tsotsou; Efthymia Simeonidi; Kalliopi Stefanaki; Amalia Patereli; Neofytos Prodromou; Nikolaos Pandis
Journal:  J Neurooncol       Date:  2013-04-24       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.